The healthcare landscape is experiencing a development with the introduction of GLP-1 transdermal systems . These innovative formulations offer a potential alternative to administering glucagon-like peptide-1 semaglutide benefits therapies for individuals living with hyperglycemia. Instead of daily shots , a convenient patch placed to the area coul